Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient - Gainey, Andrew B.; Burch, Anna‐Kathryn; Brownstein, Michael J.; Brown, David E.; Fackler, Joseph; Horne, Bri'Anna; Biswas, Biswajit; Bivens, Brittany N.; Malagon, Francisco; Daniels, Robert (Pediatric pulmonology, 2020)
Keywords: Achromobacter; Anti-Bacterial Agents - administration & dosage; Antibiotics; bacteriophage; Bacteriophages; Boronic Acids - administration & dosage; Cefiderocol; Cephalosporins - administration & dosage; Child; Combined Modality Therapy; Cystic fibrosis; Cystic Fibrosis - drug therapy; Drug Combinations; Drug resistance; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections - drug therapy; Heterocyclic Compounds, 1-Ring - administration & dosage; Humans; meropenem; Meropenem - administration & dosage; Pediatrics; Phages; cefiderocol; meropenem; bacteriophage; cystic fibrosis; achromobacter